These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Angiotensin II and the vascular phenotype in hypertension. Savoia C; Burger D; Nishigaki N; Montezano A; Touyz RM Expert Rev Mol Med; 2011 Mar; 13():e11. PubMed ID: 21450123 [TBL] [Abstract][Full Text] [Related]
3. Intracellular mechanisms involved in vascular remodelling of resistance arteries in hypertension: role of angiotensin II. Touyz RM Exp Physiol; 2005 Jul; 90(4):449-55. PubMed ID: 15890798 [TBL] [Abstract][Full Text] [Related]
4. Reactive oxygen species and angiotensin II signaling in vascular cells -- implications in cardiovascular disease. Touyz RM Braz J Med Biol Res; 2004 Aug; 37(8):1263-73. PubMed ID: 15273829 [TBL] [Abstract][Full Text] [Related]
5. Angiotensin II, NADPH oxidase, and redox signaling in the vasculature. Nguyen Dinh Cat A; Montezano AC; Burger D; Touyz RM Antioxid Redox Signal; 2013 Oct; 19(10):1110-20. PubMed ID: 22530599 [TBL] [Abstract][Full Text] [Related]
7. Angiotensin II induces Fat1 expression/activation and vascular smooth muscle cell migration via Nox1-dependent reactive oxygen species generation. Bruder-Nascimento T; Chinnasamy P; Riascos-Bernal DF; Cau SB; Callera GE; Touyz RM; Tostes RC; Sibinga NE J Mol Cell Cardiol; 2014 Jan; 66():18-26. PubMed ID: 24445059 [TBL] [Abstract][Full Text] [Related]
8. Redox-dependent signalling by angiotensin II and vascular remodelling in hypertension. Touyz RM; Tabet F; Schiffrin EL Clin Exp Pharmacol Physiol; 2003 Nov; 30(11):860-6. PubMed ID: 14678251 [TBL] [Abstract][Full Text] [Related]
9. Redox-sensitive signaling by angiotensin II involves oxidative inactivation and blunted phosphorylation of protein tyrosine phosphatase SHP-2 in vascular smooth muscle cells from SHR. Tabet F; Schiffrin EL; Callera GE; He Y; Yao G; Ostman A; Kappert K; Tonks NK; Touyz RM Circ Res; 2008 Jul; 103(2):149-58. PubMed ID: 18566342 [TBL] [Abstract][Full Text] [Related]
10. Angiotensin II and endothelin-1 regulate MAP kinases through different redox-dependent mechanisms in human vascular smooth muscle cells. Touyz RM; Yao G; Viel E; Amiri F; Schiffrin EL J Hypertens; 2004 Jun; 22(6):1141-9. PubMed ID: 15167449 [TBL] [Abstract][Full Text] [Related]
11. Diallyl Trisulfide Suppresses Angiotensin II-Induced Vascular Remodeling Via Inhibition of Mitochondrial Fission. Lu ZY; Qi J; Yang B; Cao HL; Wang RY; Wang X; Chi RF; Guo CL; Yang ZM; Liu HM; Li B Cardiovasc Drugs Ther; 2020 Oct; 34(5):605-618. PubMed ID: 32564303 [TBL] [Abstract][Full Text] [Related]
12. Recent advances in angiotensin II signaling. Touyz RM; Berry C Braz J Med Biol Res; 2002 Sep; 35(9):1001-15. PubMed ID: 12219172 [TBL] [Abstract][Full Text] [Related]
13. Vasculoprotective effects of rosiglitazone through modulating renin-angiotensin system in vivo and vitro. Ren L; Liu N; Zhi H; Li Y; Li Y; Tang R; Sheng Z Cardiovasc Diabetol; 2011 Jan; 10():10. PubMed ID: 21269478 [TBL] [Abstract][Full Text] [Related]
14. Negative regulation of RhoA/Rho kinase by angiotensin II type 2 receptor in vascular smooth muscle cells: role in angiotensin II-induced vasodilation in stroke-prone spontaneously hypertensive rats. Savoia C; Tabet F; Yao G; Schiffrin EL; Touyz RM J Hypertens; 2005 May; 23(5):1037-45. PubMed ID: 15834290 [TBL] [Abstract][Full Text] [Related]